Literature DB >> 23776211

Genetic reconstitution of tumorigenesis in primary intestinal cells.

Kunishige Onuma1, Masako Ochiai, Kaoru Orihashi, Mami Takahashi, Toshio Imai, Hitoshi Nakagama, Yoshitaka Hippo.   

Abstract

Animal models for human colorectal cancer recapitulate multistep carcinogenesis that is typically initiated by activation of the Wnt pathway. Although potential roles of both genetic and environmental modifiers have been extensively investigated in vivo, it remains elusive whether epithelial cells definitely require interaction with stromal cells or microflora for tumor development. Here we show that tumor development could be simply induced independently of intestinal microenvironment, even with WT murine primary intestinal cells alone. We developed an efficient method for lentiviral transduction of intestinal organoids in 3D culture. Despite seemingly antiproliferative effects by knockdown of adenomatous polyposis coli (APC), we managed to reproducibly induce APC-inactivated intestinal organoids. As predicted, these organoids were constitutively active in the Wnt signaling pathway and proved tumorigenic when injected into nude mice, yielding highly proliferative tubular epithelial glands accompanied by prominent stromal tissue. Consistent with cellular transformation, tumor-derived epithelial cells acquired sphere formation potential, gave rise to secondary tumors on retransplantation, and highly expressed cancer stem cell markers. Inactivation of p53 or phosphatase and tensin homolog deleted from chromosome 10, or activation of Kras, promoted tumor development only in the context of APC suppression, consistent with earlier genetic studies. These findings clearly indicated that genetic cooperation for intestinal tumorigenesis could be essentially recapitulated in intestinal organoids without generating gene-modified mice. Taken together, this in vitro model for colon cancer described herein could potentially provide unique opportunities for carcinogenesis studies by serving as a substitute or complement to the currently standard approaches.

Entities:  

Keywords:  Matrigel; colon carcinogenesis; primary culture; shRNA; validation

Mesh:

Substances:

Year:  2013        PMID: 23776211      PMCID: PMC3703980          DOI: 10.1073/pnas.1221926110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.

Authors:  Ying Feng; Guido T Bommer; Jenny Zhao; Maranne Green; Evan Sands; Yali Zhai; Kelly Brown; Aaron Burberry; Kathleen R Cho; Eric R Fearon
Journal:  Gastroenterology       Date:  2011-05-18       Impact factor: 22.682

4.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

Review 5.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.

Authors:  Koji Aoki; Makoto M Taketo
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

6.  Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.

Authors:  N Yamashita; T Minamoto; A Ochiai; M Onda; H Esumi
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

7.  Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.

Authors:  Timothy K Starr; Raha Allaei; Kevin A T Silverstein; Rodney A Staggs; Aaron L Sarver; Tracy L Bergemann; Mihir Gupta; M Gerard O'Sullivan; Ilze Matise; Adam J Dupuy; Lara S Collier; Scott Powers; Ann L Oberg; Yan W Asmann; Stephen N Thibodeau; Lino Tessarollo; Neal G Copeland; Nancy A Jenkins; Robert T Cormier; David A Largaespada
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

10.  Colorectal carcinogenesis: Review of human and experimental animal studies.

Authors:  Takuji Tanaka
Journal:  J Carcinog       Date:  2009
View more
  52 in total

Review 1.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

Review 2.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 3.  The third dimension: new developments in cell culture models for colorectal research.

Authors:  Joana F S Pereira; Nikhil T Awatade; Cláudia A Loureiro; Paulo Matos; Margarida D Amaral; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

4.  Identification and Isolation of Human LGR5+ Cells Using an Antibody-Based Strategy.

Authors:  Michael K Dame; Sha Huang; Durga Attili; Jason R Spence; Justin A Colacino
Journal:  Methods Mol Biol       Date:  2020

Review 5.  Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.

Authors:  Zehong Yang; Hongyan Xu; Xiaojun Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

6.  PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis.

Authors:  Moon Jong Kim; Bo Xia; Han Na Suh; Sung Ho Lee; Sohee Jun; Esther M Lien; Jie Zhang; Kaifu Chen; Jae-Il Park
Journal:  Dev Cell       Date:  2018-03-12       Impact factor: 12.270

7.  High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor.

Authors:  Yu Okazawa; Kosuke Mizukoshi; Yu Koyama; Shoki Okubo; Hiromitsu Komiyama; Yutaka Kojima; Michitoshi Goto; Sonoko Habu; Okio Hino; Kazuhiro Sakamoto; Akira Orimo
Journal:  J Vis Exp       Date:  2018-06-14       Impact factor: 1.355

8.  Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.

Authors:  Mami Matano; Shoichi Date; Mariko Shimokawa; Ai Takano; Masayuki Fujii; Yuki Ohta; Toshiaki Watanabe; Takanori Kanai; Toshiro Sato
Journal:  Nat Med       Date:  2015-02-23       Impact factor: 53.440

9.  Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells.

Authors:  Taku Sato; Mami Morita; Ryota Tanaka; Yui Inoue; Miyuki Nomura; Yoshimi Sakamoto; Koh Miura; Shigemi Ito; Ikuro Sato; Nobuyuki Tanaka; Jiro Abe; Satomi Takahashi; Masaaki Kawai; Masami Sato; Yoshitaka Hippo; Hiroshi Shima; Yoshinori Okada; Nobuhiro Tanuma
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

Review 10.  Patient-derived organoid models help define personalized management of gastrointestinal cancer.

Authors:  M R Aberle; R A Burkhart; H Tiriac; S W M Olde Damink; C H C Dejong; D A Tuveson; R M van Dam
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.